Additionally, the majority of the mentioned studies assessed PLIN2 in NAFLD or non-alcoholic steatohepatitis (NASH) instead of cirrhosis, further reducing the comparability of the results. This evidence concerns the gene PLIN2 and metabolic dysfunction-associated steatohepatitis.